Vascular Biogenics Priced, Nasdaq: VBLT

Developing gene therapies for cancer and small molecules for inflammation.

Industry: Health Care

Latest Trade: $5.55 0.00 (0.0%)

First Day Return: -2.5%

Return from IPO: -7.5%

Industry: Health Care

Developing gene therapies for cancer and small molecules for inflammation.
more less
IPO News for Vascular Biogenics
more
IPO Data
IPO File Date 06/06/2014
Offer Price $6.00
Price Range $13.00 - $15.00
Offer Shares (mm) 6.7
Deal Size ($mm) $40
IPO Data
IPO Date 09/30/2014
Offer Price $6.00
Price Range $13.00 - $15.00
Offer Shares (mm) 6.7
Deal Size ($mm) $40
Underwriters
more
Company Data
Headquarters Or Yehuda, Israel
Founded 2000
Employees 32
Website www.vblrx.com